6th Jul 2012 16:41
- US non-farm payrolls disappoint - Miners drag the Footsie lower - IMF to cut global GDP forecast After treading water for the morning session, the Footsie dropped in afternoon trade after a disappointing employment report from the US dampened the outlook for the global economy. The US Labor Depa
Read more6th Jul 2012 11:37
- Markets look ahead to US jobs report - Investors shrug off central bank action - Aviva jumps on Delta Lloyds disposal The Footsie was trading within a narrow range on Friday morning as investors showed caution ahead of a pivotal employment report due out in the US in the coming hours. Stocks o
Read more6th Jul 2012 11:31
Jefferies has downgraded its recommendation for pharmaceuticals giant AstraZeneca from 'buy' to hold' after the recent strong performance in the shares. "The shares have traded as low as 2,578p during the last few months as weak markets and irrational fears over potential large-scale M&A that could
Read more6th Jul 2012 10:48
Jefferies has downgraded its recommendation for pharmaceuticals giant AstraZeneca from 'buy' to hold' after the recent strong performance in the shares. "The shares have traded as low as 2,578p during the last few months as weak markets and irrational fears over potential large-scale M&A that could
Read more6th Jul 2012 09:35
Aviva: SocGen upgrades to hold from sell. Aberdeen: UBS cuts target from 310p to 300p, buy rating unchanged. Associated British Foods: Nomura raises target from 1,375p to 1,400p, buy recommendation unchanged. AstraZeneca: Jefferies downgrades from buy to hold, target left at 2,975p. AVEVA: Beren
Read more3rd Jul 2012 06:54
Industrial estates don't often set the heart racing but Questor in the Telegraph is rather partial to the logistics hubs owned by property firm Segro. The firm has just spent 130m pounds on a portfolio of warehouse estates in Paris and Lyon. This may look risky in the current euro-infected climate
Read more2nd Jul 2012 11:41
- Better-than-expected manufacturing data from Asia - Eurozone jobless rate at all-time high - UK manufacturing PMI beats forecasts London's blue-chip index held on to gains on Monday morning with Barclays leading the risers as it continues to rebound after last week's sharp falls. Economic data f
Read more2nd Jul 2012 08:30
- Chinese, Japanese data comes in better than expected - RBS falls on Libor issues - Barclays Chairman resigns London's blue chips edged higher on Monday morning after manufacturing data in China and Japan boosted sentiment. China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last mont
Read more2nd Jul 2012 07:50
AstraZeneca (AZN) has said that it will benefit from Bristol-Myers Squibb's (BMS's) acquisition of Amylin Pharmaceuticals as it strengthens the leadership position of its diabetes alliance with BMS in a 'growing area of high unmet medical need'. US biopharmaceutical giant BMS has announced on Monda
Read more22nd Jun 2012 15:51
Anglo-Swedish drugs developer AstraZeneca said its Zinforo skin infection treatment has been given a positive verdict by the Committee for Medicinal Products for Human Use (CHMP). The CHMP's positive opinion will now be reviewed by the European Commission, which has the authority to approve medicin
Read more21st Jun 2012 08:40
- Chinese PMI falls to seven-month low - Fed extends 'the twist', lowers GDP forecast - Miners provide a drag in London Disappointing economic data from China and a downward revision to US growth dented the Footsie in early trading on Thursday, with mining stocks bearing the brunt of the sell-off.
Read more20th Jun 2012 11:31
- Stocks pare losses after MPC minutes - Markets await the Fed decision later today - Aviva, ITV and Sage gain; ex-div stocks drag The Bank of England's (BoE's) vote on maintaining its asset purchase programme proved to be a contentious issue last month and the news provided a boost to stock market
Read more20th Jun 2012 08:43
- Eyes on the MPC, Greece and FOMC - Ex-div stocks dampen Footsie - ITV gains on bid rumours The Footsie slight lower on Wednesday morning with investors showing caution ahead of what is likely to be a busy day on the macro-economic front; all eyes will be on the Bank of England (BoE), Greek leader
Read more20th Jun 2012 07:22
AstraZeneca said it had successfully completed its acquisition of California-based biotechnology company Ardea Biosciences. The pharmaceutical giant said the $1.2bn deal would strengthen its late-stage pipeline with the addition of lesinurad, which is aimed at patients with gout. Astra paid $32 pe
Read more18th Jun 2012 06:46
Small businesses are facing a new credit crunch that is denting confidence and restricting growth even as the UK government launches an 80bn pound scheme to boost lending. In research published yesterday, the Federation of Small Businesses (FSB) said banks are rejecting more than four in ten firms t
Read more